Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis. - Wikidata - awgldk - TriplyDB

Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis.

Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis.

http://www.wikidata.org/entity/Q34010668

about

Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs Antioxidant activity of nitro derivative of aspirin against ischemia-reperfusion in hamster cheek pouch microcirculation Potential cardioprotective actions of no-releasing aspirin Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders Therapeutic effects of nitric oxide-aspirin hybrid drugs Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.Age-related changes in redox signaling and VSMC function.Novel antiplatelet agents in the prevention of cardiovascular complications--focus on ticagrelor.Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin Flow injection measurements of S-nitrosothiols species in biological samples using amperometric nitric oxide sensor and soluble organoselenium catalyst reagent Recent developments in nitric oxide donor drugs.Differential modulation of nitric oxide synthases in aging: therapeutic opportunities.Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential.Novel therapies targeting vascular endothelium.Antioxidative effect of aspirin on vascular function of aged ovariectomized rats.Review: Antiplatelet drugs: what comes next?Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid.An imbalance between VEGF and endostatin underlies impaired angiogenesis in gastric mucosa of aging rats.Effects of endothelium, stent design and deployment on the nitric oxide transport in stented artery: a potential role in stent restenosis and thrombosis.Antiplatelet drugs

P2860

Q24672983-E4742CA1-7FAC-44AE-8D37-DB9E6BDB100E Q28165690-006CFC53-41CB-4A90-88F5-22B032B10AD3 Q28193422-72C9195C-2F75-4F31-A160-FAB874A9FE25 Q28200449-ED36791D-023E-4AD6-9A05-C9256829075F Q28210282-06BB02F9-B708-4B60-8E6A-D975FD3720B4 Q31119076-5DBB1F46-B26E-436F-8B3A-202612B98E8B Q33830145-2C089E7E-BC36-403B-B924-E51E8738DEB0 Q33902628-7F52D972-3055-4D07-950A-180DBDE21A52 Q34156437-524EF32F-17BF-4C26-96E5-A41D0555497A Q34574584-1A7BDFD5-3080-4BBA-9C45-93CBF13FD1A3 Q35308383-F5386299-0EA7-417B-A122-CFD21730CAEF Q36052815-8EFC080A-5EB0-4573-BB8D-54021CA3F3E6 Q36056243-6D7E9F2C-8057-46D0-ABD3-03A69DAB7ABF Q36196462-D76737F8-B90B-4965-AC1C-1F53E2B6D665 Q36684472-58F40148-8441-4DDF-802E-7D5A23175E11 Q37471020-FF20A8B6-C252-4DF6-95B1-8930ACA56466 Q37809630-F9DDFC2A-DE36-42F5-9EF9-7F1AE9BD97BA Q38558587-FF93BD26-605F-440C-A279-635D14ADE78A Q44823899-3062B6E6-EFF8-4DF6-BEF7-5DBDCF2F3B8F Q46200461-D7CB43BE-A144-49F8-97EC-821FC5681897 Q52657697-5BF1F494-F82E-42D5-9C09-02340AA3D40B Q58481433-AD338596-E7B5-40AA-82F0-E8D52074710D

P2860

Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis.

http://www.wikidata.org/entity/Q34010668

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Efficacy and age-related effec ...... in on experimental restenosis.

@ast

Efficacy and age-related effec ...... in on experimental restenosis.

@en

Efficacy and age-related effec ...... in on experimental restenosis.

@nl

type

label

Efficacy and age-related effec ...... in on experimental restenosis.

@ast

Efficacy and age-related effec ...... in on experimental restenosis.

@en

Efficacy and age-related effec ...... in on experimental restenosis.

@nl

prefLabel

Efficacy and age-related effec ...... in on experimental restenosis.

@ast

Efficacy and age-related effec ...... in on experimental restenosis.

@en

Efficacy and age-related effec ...... in on experimental restenosis.

@nl

P1433

Q34010668-3FD8F161-9F34-435D-9259-2E11049B6FAA

P1476

Q34010668-A303A454-B984-42FE-975C-07985C7F63B6

P2093

Q34010668-0868072A-0270-4087-8E8C-4E3B82B1CD45

Q34010668-17C81707-F759-4B89-809F-A8678357D5AD

Q34010668-2C1314E9-E096-4627-9D08-390ECF2A66B7

Q34010668-422F036F-2A5E-4B61-A855-82DD3A79ECCD

Q34010668-7040188F-6094-487E-BEEF-CE150F443827

Q34010668-923E4223-D834-49B1-B3CF-38C74286387F

Q34010668-B361D5F6-71B1-46DF-AA3F-3FD4F0C0125C

P2860

Q34010668-1013CC1F-2E44-4DD9-8ABB-E3A792CE4AB7

Q34010668-147EBBCF-3E4D-410A-8D4E-419093F8C2E7

Q34010668-1756EC08-C66E-48B4-908E-410E7D1462DD

Q34010668-1EDBC24A-1E78-4D2A-9EA7-481ABE5E1F03

Q34010668-217A57E4-E73B-4F46-B579-5DF92212CE5D

Q34010668-28BEDEB2-071E-4949-BCBA-03FE950EB249

Q34010668-30B0FA1B-7BE2-4801-9E75-19388C01B4C8

Q34010668-352067C3-9732-422A-957E-724B3DE1125F

Q34010668-37A34826-5B95-43C7-8DF9-4D509D232CA7

Q34010668-37EDB05F-1E89-4278-BEC4-5885CED6C03B

P304

Q34010668-7A9D1516-C676-4A3D-A5AF-7B080FF61E6F

P31

Q34010668-BB8CC591-4EAD-4655-ACED-2482A6E7DB01

P356

Q34010668-C903C151-9262-467E-8121-879E4E6AD232

P407

Q34010668-C880B7E2-52A4-477D-92A3-B1968F3B199C

P433

Q34010668-282DB5E3-0C00-41A6-B746-AA18F019E0D6

P478

Q34010668-4AA61870-C774-48BF-92B9-2ECCEC20926C

P50

Q34010668-11B03899-711F-4433-851F-D0938FC01664

Q34010668-2BD83304-82BA-4BD6-9F87-6618B31F2357

Q34010668-608CAC64-5D2B-472F-BA47-0402EA106C81

Q34010668-76BC9EE2-344A-4B84-9373-1A1D24269DF2

Q34010668-B5AC4317-6E2E-450B-AE55-F2E63658BA4A

Q34010668-BF13A41D-D780-4202-82A2-32523EBE375F

Q34010668-DE3B2003-5D08-4C09-8866-2504C46FE68C

Q34010668-EC512CAE-2E87-40D4-A913-1C29AA9721FA

Q34010668-F76EE44F-B0D1-4CC5-99F4-6F0BAD4766CE

P577

Q34010668-37983A10-49AF-4D16-BFA9-FDDAF64285F3

P5875

Q34010668-6463EACF-C941-47A4-B956-05890AB9247B

P698

Q34010668-C086C747-EB71-4C93-AC7F-0A906332C3D9

P921

Q34010668-7E8B098A-25FF-4503-AA37-492DFA8DA798

P932

Q34010668-D050E5ED-055F-4FAF-BC7F-382FB3D709B1

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Efficacy and age-related effec ...... rin on experimental restenosis

@en

P2093

Chiara Mignogna

http://www.w3.org/2001/XMLSchema#string

Gianluigi Condorelli

http://www.w3.org/2001/XMLSchema#string

John L Wallace

http://www.w3.org/2001/XMLSchema#string

Louis J Ignarro

http://www.w3.org/2001/XMLSchema#string

Mario Condorelli

http://www.w3.org/2001/XMLSchema#string

Roberto Maffei

http://www.w3.org/2001/XMLSchema#string

Vincenzo Sica

http://www.w3.org/2001/XMLSchema#string

P2860

A mutant with a defect in telomere elongation leads to senescence in yeast.

Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA

The nitroderivative of aspirin, NCX 4016, reduces infarct size caused by myocardial ischemia-reperfusion in the anesthetized rat

Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation

Telomeres shorten during ageing of human fibroblasts

Reductive assays for S-nitrosothiols: implications for measurements in biological systems.

LC coupled to ion-trap MS for the rapid screening and detection of polyphenol antioxidants from Helichrysum stoechas.

Export by red blood cells of nitric oxide bioactivity.

Nitric oxide and hemoglobin interactions in the vasculature.

The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: analysis and recommendations. On behalf of the Subcommittee on Animal, Cellular and Molecular Models of Thrombosis and Haemostasis of

P304

1689-1694

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.022639399

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Giancarlo Aldini

Gaetano De Rosa

Francesco P. D'Armiento

Filomena de Nigris

Domenico Bonaduce

Lilach O. Lerman

P577

2002-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11540618

http://www.w3.org/2001/XMLSchema#string

P698

11818533

http://www.w3.org/2001/XMLSchema#string

P921

P932

122252

http://www.w3.org/2001/XMLSchema#string